Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar ayuddha (< 20) Submitted: 7/15/2012 5:18:50 PM : Outperform Start Price: $17.39 ARIA Score: -27.40

It was picked by www.hechtsoft.de Trade Alerts.

Featured Broker Partners


Advertisement